{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T07:32:10Z","timestamp":1777707130376,"version":"3.51.4"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T00:00:00Z","timestamp":1504137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Instytut Medycyny Wsi im. W. Chodzki (PL)","award":["14030\/2015-2016"],"award-info":[{"award-number":["14030\/2015-2016"]}]},{"name":"Uniwersytet Medyczny w Lublinie (PL)","award":["DS 474\/2016-2017"],"award-info":[{"award-number":["DS 474\/2016-2017"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0183873","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T17:40:14Z","timestamp":1504201214000},"page":"e0183873","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of arachidonyl-2\u2019-chloroethylamide (ACEA) on the protective action of various antiepileptic drugs in the 6-Hz corneal stimulation model in mice"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3059-0393","authenticated-orcid":true,"given":"Jarogniew J.","family":"Luszczki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel","family":"Patrzylas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslaw","family":"Zagaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Andres-Mach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Zaluska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria W.","family":"Kondrat-Wrobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Szpringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslaw","family":"Chmielewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Florek-Luszczki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,8,31]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra1004418","article-title":"Drug-resistant epilepsy","volume":"365","author":"P Kwan","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.seizure.2011.01.004","article-title":"Combining antiepileptic drugs\u2014rational polytherapy?","volume":"20","author":"MJ Brodie","year":"2011","journal-title":"Seizure"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1528-1157.2000.tb00111.x","article-title":"Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed","volume":"41","author":"CL Deckers","year":"2000","journal-title":"Epilepsia"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1734-1140(09)70024-6","article-title":"Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions","volume":"61","author":"JJ Luszczki","year":"2009","journal-title":"Pharmacol Rep"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.1360-0443.1996.tb02264.x","article-title":"Cannabis: pharmacology and toxicology in animals and humans","volume":"91","author":"IB Adams","year":"1996","journal-title":"Addiction"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/j.1476-5381.2012.02207.x","article-title":"Cannabidivarin is anticonvulsant in mouse and rat","volume":"167","author":"AJ Hill","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1476-5381.1980.tb14562.x","article-title":"Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice","volume":"68","author":"R Karler","year":"1980","journal-title":"Br J Pharmacol"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1523\/JNEUROSCI.02-04-00443.1982","article-title":"Cannabinoids inhibit calcium uptake by brain synaptosomes","volume":"2","author":"RA Harris","year":"1982","journal-title":"J Neurosci"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1124\/jpet.115.230151","article-title":"The pharmacological basis of cannabis therapy for epilepsy","volume":"357","author":"DS Reddy","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1358\/dof.2014.039.012.2243535","article-title":"Future prospects for cannabinoids and endogenous cannabinoid system in the epileptic brain\u2013a short overview of the latest scientific reports","volume":"39","author":"M Andres-Mach","year":"2014","journal-title":"Drugs Fut"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nbd.2014.10.018","article-title":"Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212\u20132 prevents chronic epileptic hippocampal damage in rats","volume":"73","author":"R Di Maio","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.103.051920","article-title":"The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy","volume":"307","author":"MJ Wallace","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(01)01243-2","article-title":"Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects","volume":"428","author":"MJ Wallace","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00702-014-1173-7","article-title":"Effects of WIN 55,212\u20132 (a non-selective cannabinoid CB1 and CB 2 receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6 Hz psychomotor seizure model","volume":"121","author":"M Florek-Luszczki","year":"2014","journal-title":"J Neural Transm"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2015.01.003","article-title":"Effects of WIN 55,212\u20132 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice","volume":"130","author":"M Florek-Luszczki","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.eplepsyres.2014.10.004","article-title":"Influence of WIN 55,212\u20132 on the anticonvulsant and acute neurotoxic potential of clobazam and lacosamide in the maximal electroshock-induced seizure model and chimney test in mice","volume":"108","author":"M Florek-Luszczki","year":"2014","journal-title":"Epilepsy Res"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.neuropharm.2004.04.011","article-title":"The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice","volume":"47","author":"H Shafaroodi","year":"2004","journal-title":"Neuropharmacology"},{"issue":"2\u20133","key":"ref18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.eplepsyres.2009.01.003","article-title":"Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB(1) agonist ACEA in the pentylenetetrazole-induced seizure in mice","volume":"84","author":"A Bahremand","year":"2009","journal-title":"Epilepsy Res"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.eplepsyres.2008.04.010","article-title":"The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice","volume":"81","author":"A Bahremand","year":"2008","journal-title":"Epilepsy Res"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pnpbp.2012.07.001","article-title":"Effect of ACEA\u2014a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model","volume":"39","author":"M Andres-Mach","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/fcp.12123","article-title":"Influence of arachidonyl-2'-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the anticonvulsant and acute side-effect potentials of clobazam, lacosamide, and pregabalin in the maximal electroshock-induced seizure model and chimney test in mice","volume":"29","author":"M Florek-Luszczki","year":"2015","journal-title":"Fund Clin Pharmacol"},{"issue":"1\u20133","key":"ref22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2006.07.037","article-title":"Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model","volume":"547","author":"JJ Luszczki","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pnpbp.2009.09.005","article-title":"Effect of arachidonyl-2'-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the protective action of the various antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"34","author":"JJ Luszczki","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1528-1167.2009.02098.x","article-title":"The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats","volume":"50","author":"R Kozan","year":"2009","journal-title":"Epilepsia"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11064-011-0607-y","article-title":"L-type calcium channel mediates anticonvulsant effect of cannabinoids in acute and chronic murine models of seizure","volume":"37","author":"N Naderi","year":"2012","journal-title":"Neurochem Res"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0022-3565(24)38289-8","article-title":"Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1)","volume":"289","author":"CJ Hillard","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.bjp.0705666","article-title":"The endocannabinoid system: a general view and latest additions","volume":"141","author":"L De Petrocellis","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0022-3565(24)37121-6","article-title":"The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity","volume":"283","author":"DR Compton","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"ME Barton","year":"2001","journal-title":"Epilepsy Res"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eplepsyres.2003.08.001","article-title":"Comparison of the effect of glutamate receptor modulators in the 6 Hz and maximal electroshock seizure models","volume":"56","author":"ME Barton","year":"2003","journal-title":"Epilepsy Res"},{"issue":"7","key":"ref31","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/epi.12237","article-title":"Synergism of lacosamide with established antiepileptic drugs in the 6-Hz seizure model in mice","volume":"54","author":"A Shandra","year":"2013","journal-title":"Epilepsia"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.euroneuro.2005.03.005","article-title":"Levetiracetam selectively potentiates the acute neurotoxic effects of topiramate and carbamazepine in the rotarod test in mice","volume":"15","author":"JJ Luszczki","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pnpbp.2015.10.005","article-title":"Influence of MPEP (a selective mGluR5 antagonist) on the anticonvulsant action of novel antiepileptic drugs against maximal electroshock-induced seizures in mice","volume":"65","author":"D Zolkowska","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5114\/hpc.2016.58209","article-title":"Interaction of three-drug combination of lacosamide, carbamazepine and phenobarbital in the mouse maximal electroshock-induced seizure model\u2013an isobolographic analysis","volume":"10","author":"MW Kondrat-Wr\u00f3bel","year":"2016","journal-title":"Health Prob Civil"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ejphar.2013.10.063","article-title":"Interactions of levetiracetam with carbamazepine, phenytoin, topiramate and vigabatrin in the mouse 6Hz psychomotor seizure model\u2014a type II isobolographic analysis","volume":"723","author":"M Florek-Luszczki","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"2\u20133","key":"ref36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.eplepsyres.2009.06.003","article-title":"Isobolographic characterization of interactions of levetiracetam with the various antiepileptic drugs in the mouse 6 Hz psychomotor seizure model","volume":"86","author":"E Wojda","year":"2009","journal-title":"Epilepsy Res"},{"key":"ref37","first-page":"281","article-title":"Progressive seizure aggravation in the repeated 6-Hz corneal stimulation model is accompanied by marked increase in hippocampal p-ERK1\/2 immunoreactivity in neurons","volume":"10","author":"C Giordano","year":"2016","journal-title":"Front Cel Neurosci"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"e0141221","DOI":"10.1371\/journal.pone.0141221","article-title":"Repeated 6-Hz corneal stimulation progressively increases FosB\/DeltaFosB levels in the lateral amygdala and induces seizure generalization to the hippocampus","volume":"10","author":"C Giordano","year":"2015","journal-title":"PloS one"},{"issue":"3","key":"ref39","first-page":"233","article-title":"A method for the routine assessment of fore- and hindlimb grip strength of rats and mice","volume":"1","author":"OA Meyer","year":"1979","journal-title":"Neurobehav Toxicol"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1734-1140(09)70128-8","article-title":"Characterization of acute adverse-effect profiles of selected antiepileptic drugs in the grip-strength test in mice","volume":"61","author":"A Zadrozniak","year":"2009","journal-title":"Pharmacol Rep"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000134913","article-title":"Une nouvelle m\u00e9thode simple pour explorer l\u2019action \u00abtranquillisante\u00bb: le test de la chemin\u00e9e","volume":"3","author":"JR Boissier","year":"1960","journal-title":"Pharmacology"},{"issue":"6073","key":"ref42","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","article-title":"Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks","volume":"321","author":"P Venault","year":"1986","journal-title":"Nature"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.npp.1300602","article-title":"Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis","volume":"30","author":"JJ Luszczki","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.npp.1300243","article-title":"Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice","volume":"28","author":"JJ Luszczki","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"ref45","first-page":"1","article-title":"Encyclopedia of Psychopharmacology","author":"SO \u00d6gren","year":"2010"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"JT Litchfield Jr.","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"issue":"2\u20133","key":"ref47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejphar.2008.11.049","article-title":"Isobolographic analysis of interactions between 1-methyl-1,2,3,4-tetrahydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"602","author":"JJ Luszczki","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ejphar.2016.09.029","article-title":"Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2'-chloroethylamide and WIN 55,212\u20132 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA\/2 mice","volume":"791","author":"R Citraro","year":"2016","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pbb.2011.01.002","article-title":"Synthetic cannabinoid WIN 55,212\u20132 mesylate enhances the protective action of four classical antiepileptic drugs against maximal electroshock-induced seizures in mice","volume":"98","author":"JJ Luszczki","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"issue":"1\u20133","key":"ref50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejphar.2013.10.020","article-title":"Effects of WIN 55,212\u20132 mesylate on the anticonvulsant action of lamotrigine, oxcarbazepine, pregabalin and topiramate against maximal electroshock-induced seizures in mice","volume":"720","author":"JJ Luszczki","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"2\u20133","key":"ref51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(98)00410-5","article-title":"Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy","volume":"353","author":"H Klitgaard","year":"1998","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"ref52","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"C Kilkenny","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1734-1140(10)70355-8","article-title":"Dose-response relationship analysis of pregabalin doses and their antinociceptive effects in hot-plate test in mice","volume":"62","author":"JJ Luszczki","year":"2010","journal-title":"Pharmacol Rep"},{"issue":"3","key":"ref54","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S1734-1140(12)70867-8","article-title":"Synergistic interaction of pregabalin with the synthetic cannabinoid WIN 55,212\u20132 mesylate in the hot-plate test in mice: an isobolographic analysis","volume":"64","author":"JJ Luszczki","year":"2012","journal-title":"Pharmacol Rep"},{"issue":"8","key":"ref55","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/j.1528-1167.2009.02485.x","article-title":"Effect of sildenafil on the anticonvulsant action of classical and second-generation antiepileptic drugs in maximal electroshock-induced seizures in mice","volume":"51","author":"D Nieoczym","year":"2010","journal-title":"Epilepsia"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0183873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T11:58:14Z","timestamp":1750852694000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0183873"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Biagini","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,31]]},"references-count":55,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0183873","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,31]]}}}